FDA Clears Freespira for Teens 13-17; At-Home Treatment Cuts Panic and PTSD Symptoms

Freespira, Inc., developer of the first FDA-cleared at-home treatment for panic disorder and PTSD, has received FDA 510(k) clearance to extend use to adolescents aged 13-17. Freespira remains the only prescription, drug-free therapy that targets the physiological root causes of these conditions with real-time, software-guided breathing and personalized coaching.